Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. (Q48359732)

11 February 2018

title

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. (English)

1 reference

11 February 2018

main subject

arterial hypertension

0 references

0 references

1 reference

1 reference

systolic hypertension

1 reference

3

1 reference

11 February 2018

Jaakko Tuomilehto

14

object named as

J Tuomilehto

1 reference

11 February 2018

author name string

F Forette

1

1 reference

11 February 2018

M L Seux

2

1 reference

11 February 2018

L Thijs

4

1 reference

11 February 2018

W H Birkenhäger

5

1 reference

11 February 2018

M R Babarskiene

6

1 reference

11 February 2018

S Babeanu

7

1 reference

11 February 2018

A Bossini

8

1 reference

11 February 2018

B Gil-Extremera

9

1 reference

11 February 2018

X Girerd

10

1 reference

11 February 2018

T Laks

11

1 reference

11 February 2018

E Lilov

12

1 reference

11 February 2018

V Moisseyev

13

1 reference

11 February 2018

H Vanhanen

15

1 reference

11 February 2018

J Webster

16

1 reference

11 February 2018

Y Yodfat

17

1 reference

11 February 2018

R Fagard

18

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 October 1998

1 reference

11 February 2018

published in

The Lancet

1 reference

11 February 2018

volume

352

1 reference

11 February 2018

page(s)

1347-1351

1 reference

11 February 2018

issue

9137

1 reference

11 February 2018

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

Hypertension and the risk of dementia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

1 reference

7 January 2021

The meaning of cognitive impairment in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

Validity of the Mini-Mental State examination as a screening instrument for cognitive impairment and dementia in French elderly community residents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

Overview of Incidence Studies of Dementia Conducted in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

Diagnostic evaluation of degenerative and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

Cerebral blood flow in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

Decreased cerebral blood flow precedes multi-infarct dementia, but follows senile dementia of Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

Analysis of serial measurements in medical research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

The effect of different diagnostic criteria on the prevalence of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

Cognitive enhancement therapy for Alzheimer's disease. The way forward

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

Autoradiographic localization of calcium channel antagonist receptors in rat brain with [3H]nitrendipine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903086-4

7 January 2021

10.1016/S0140-6736(98)03086-4

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9802273

1 reference

11 February 2018